Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction

Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGER

CENTERA THV System in Intermediate Risk Patients Who Have Symptomatic, Severe, Calcific, Aortic Stenosis Requiring Aortic Valve Replacement

Pivotal Study Of A Dual Epicardial & Endocardial Procedure (DEEP) Approach

An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE

A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients

The PARTNER 3 - AVIV Trial

The PARTNER 3 - Trial - The Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis

Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE

Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST

Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF)

Evaluation of Transcatheter Aortic Valve Replacement Compared to SurveilLance for Patients With AsYmptomatic Severe Aortic Stenosis

Empagliflozin Impact on Hemodynamics in Patients With Heart Failure

Efficacy and Safety of Etripamil for the Termination of Spontaneous PSVT. NODE-301

A Registry for Patients Taking Uptravi

An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension

Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of PSVT. NODE-302

BPS-314d-MR-PAH-303 (BEAT OLE)